Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yasmin plus metformin versus Dianette plus metformin in women with polycystic ovary syndrome and metabolic disorders
ChiCTR-TRC-11001143Phase 4Completed
- Sponsor
- West China Second University Hospital
- Start
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in polycystic ovary syndrome (PCOS) comparing Dianette + metformin + lifestyle intervention with Yasmin + metformin + lifestyle intervention (2 arms). Primary endpoints: Insulin resistance, Hyperandrogenic clinical manifestations and 2 more. Started Aug 2011; status: completed.
02
Drugs
drospirenoneethinyl estradiol + cyproteronemetformin
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on ChiCTR-TRC-11001143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001143.